PD Dr. med. Olivia Engmann

Olivia Engmann is a group leader for neuro-epigenetics in the Institute for Human Genetics at Jena University Hospital. She explores fast-acting antidepressant pathways in mouse models using viral mediated gene transfer, 3D dendritic spine imaging, next generation sequencing approaches and CRISPR epigenome editing. Promising changes in key molecular targets are then validated using human postmortem brain tissue. Dr. Engmann will be able to share technical expertise as well as large sample sets with the C-I-R-C network and hopes to translate her findings to patients via clinical trials.

Keine Kommentare